Robeco Institutional Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,354	Closed	-$804K	–	907
2024 Q4	$804K	Buy	4,354 +126	+3%	+$24.3K	﹤0.01%	802
2024 Q3	$833K	Sell	4,228 -1,107	-21%	-$230K	﹤0.01%	796
2024 Q2	$1.1M	Sell	5,335 -773	-13%	-$175K	﹤0.01%	760
2024 Q1	$1.65M	Buy	6,108 +2,758	+82%	+$659K	﹤0.01%	717
2023 Q4	$792K	Buy	3,350 +2,700	+415%	+$531K	﹤0.01%	801
2023 Q3	$127K	Sell	650 -101	-13%	-$20.7K	﹤0.01%	950
2023 Q2	$158K	Buy	751 +276	+58%	+$54.9K	﹤0.01%	955
2023 Q1	$95.9K	Buy	+475	New	+$108K	﹤0.01%	980
2022 Q4	–	Sell	-475	Closed	-$94K	–	965
2022 Q3	$94K	Sell	475 -3,904	-89%	-$843K	﹤0.01%	884
2022 Q2	$938K	Sell	4,379 -5,623	-56%	-$1.37M	﹤0.01%	706
2022 Q1	$2.84M	Sell	10,002 -10,506	-51%	-$3.24M	0.01%	614
2021 Q4	$7.73M	Sell	20,508 -110	-0.5%	-$42.7K	0.02%	488
2021 Q3	$8.51M	Buy	20,618 +6,125	+42%	+$2.54M	0.02%	485
2021 Q2	$5.36M	Buy	+14,493	New	+$4.84M	0.01%	569